Public knowledge, perception, and experience with generic medications in Saudi Arabia

References

1. ↵
   1. Stadhouders N,
   2. Kruse F,
   3. Tanke M,
   4. Koolman X,
   5. Jeurissen P

   (2019) Effective healthcare cost-containment policies:A systematic review. Health Policy 123:71–79.

   OpenUrl
2. ↵
   1. Johansen ME,
   2. Richardson C

   (2016) Estimation of potential savings through therapeutic substitution. JAMA Intern Med 176:769–775.

   OpenUrl
3. ↵
   1. Warraich HJ,
   2. Salami JA,
   3. Khera R,
   4. Valero-Elizondo J,
   5. Okunrintemi V,
   6. Nasir K

   (2018) Trends in use and expenditures of brand-name atorvastatin after introduction of generic atorvastatin. JAMA Intern Med 178:719–721.

   OpenUrl
4. ↵
   1. Hassali MA,
   2. Alrasheedy AA,
   3. McLachlan A,
   4. Nguyen TA,
   5. Al-Tamimi SK,
   6. Ibrahim MI,
   7. et al.

   (2014) The experiences of implementing generic medicine policy in eight countries:A review and recommendations for a successful promotion of generic medicine use. Saudi Pharm J 22:491–503.

   OpenUrl
5. ↵
   1. U.S.-Saudi Arabian Business Council (USSABC)

   (2017) New horizons and opportunities in the Saudi healthcare sector:USSABC, Available from URL: https://us-sabc.org/new-horizons-and-opportunities-in-the-saudi-healthcare-sector/.
6. ↵
   1. Emeka PM,
   2. Al Ahmed A

   (2017) Extents of generic prescribing in hospitals and community pharmacies for diabetic and hypertensive outpatients in Eastern region of Saudi Arabia. J Young Pharm 9:280–283.

   OpenUrl
7. ↵
   1. Alhawassi TM,
   2. Abuelizz HA,
   3. Almetwazi M,
   4. Mahmoud MA,
   5. Alghamdi A,
   6. Alruthia YS,
   7. et al.

   (2018) Advancing pharmaceuticals and patient safety in Saudi Arabia:A 2030 vision initiative. Saudi Pharm J 26:71–74.

   OpenUrl
8. ↵
   1. Albarraq A

   (2013) Consumers'perceptions on generic medicines in Taif city, Saudi Arabia. Saudi J Health Sci 2:18–22.

   OpenUrl
9. ↵
   1. Saudi Food and Drug Authority (SFDA)

   What is a generic medication? Available from URL: https://www.sfda.gov.sa/en/drug/awareness/news/pages.
10. ↵
    1. Rashidi Y,
    2. Vaniea K,
    3. Camp JL

    (2016) Understanding Saudis'privacy concerns when using WhatsApp. Usable Security and Privacy 2016 Conference;21 February 2016. San Diego:California; 1–8.
11. ↵
    1. El-Dahiyat F,
    2. Kayyali R

    (2013) Evaluating patients'perceptions regarding generic medicines in Jordan. J Pharm Policy Pract 6:3.

    OpenUrl
12. ↵
    1. Al Ameri M,
    2. Mohamed W,
    3. Makramalla E,
    4. Shalhoub B,
    5. Tucker A,
    6. Johnston A

    (2013) Renal patients'views on generic prescribing and substitution:example from the United Arab Emirates. East Mediterr Health J 19:373–381.

    OpenUrl
13. ↵
    1. Salhia HO,
    2. Ali A,
    3. Rezk NL,
    4. El Metwally A

    (2015) Perception and attitude of physicians toward local generic medicines in Saudi Arabia:A questionnaire-based study. Saudi Pharm J 23:397–404.

    OpenUrl
14. ↵
    1. Albadr Y,
    2. Khan TM

    (2015) Factors influencing community pharmacist decision to dispense generic or branded medicines;Eastern Province, Alahsa, Saudi Arabia. Saudi Pharm J 23:143–146.

    OpenUrl
15. ↵
    1. Wajid S,
    2. Al-Arifi M,
    3. Al Nomay H,
    4. Al Mousa Y,
    5. Babelghaith S

    (2015) Knowledge and perception of community pharmacists'towards generic medicines in Saudi Arabia. Biomed Res 26:800–806.

    OpenUrl
16. ↵
    1. Alkhuzaee FS,
    2. Almalki HM,
    3. Attar AY,
    4. Althubiani SI,
    5. Almuallim WA,
    6. Cheema E,
    7. et al.

    (2016) Evaluating community pharmacists'perspectives and practices concerning generic medicines substitution in Saudi Arabia:A cross-sectional study. Health Policy 120:1412–1419.

    OpenUrl
17. ↵
    1. Moe-Byrne T,
    2. Chambers D,
    3. Harden M,
    4. McDaid C

    (2014) Behaviour change interventions to promote prescribing of generic drugs:a rapid evidence synthesis and systematic review. BMJ Open 4:e004623.

    OpenUrlAbstract/FREE Full Text